Indications

Magnesium Citrate SAP can be used to replenish deficiencies which can manifest as migraines, muscle cramping, cardiovascular disease, PMS, dysmenorrhea, preeclampsia, constipation, fibromyalgia, and insomnia.

Ingredients

Each vegetable capsule contains:

Magnesium (from 850 mg magnesium citrate). 136 mg
2-Aminoethanesulfonic acid (taurine) 45 mg

Contains no: Preservatives, artificial flavor or color, sugar, dairy, starch, wheat, gluten, yeast, soy, citrus, or eggs.

Description

Magnesium deficiency is one of the most common mineral deficiencies in North America. It can contribute to a multitude of symptoms and long-term health concerns. Magnesium is an essential mineral for the optimal functioning of the cardiovascular, nervous, and musculoskeletal systems. Magnesium deficiency can also contribute to symptoms such as migraines, PMS, dysmenorrhea, muscle cramping, fibromyalgia, constipation, and insomnia. This deficiency is also commonly seen in alcoholics and patients with diabetes mellitus.

Quantity

90 capsules

Dose

1 capsule daily with food or as directed by your health-care practitioner.

References

"Show references"

"Hide references"

1. Gums, J.G. “Magnesium in cardiovascular and other disorders”. American Journal of Health-System Pharmacy Vol. 61, No. 15 (2004): 1569–1576.
2. Kaze Foleafack, F. and C. Stoermann Chopard. “Magnesium metabolism disturbances”. Revue MÉdicale Suisse Vol. 3, No. 101 (2007): 605–606, 608, 610–611.
3. Musso, C.G. “Magnesium metabolism in health and disease”. International Urology and Nephrology Vol. 41, No. 2 (2009): 357–362.
4. Nielson, F.H., et al. “Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in postmenopausal women”. Journal of the American College of Nutrition Vol. 26, No. 2 (2007): 121–132.
5. Lima, M. de L., et al. “Serum and intracellular magnesium deficiency in patients with metabolic syndrome — evidences for its relation to insulin resistance”. Diabetes Research and Clinical Practice Vol. 83, No. 2 (2009): 257–262. 6. Rude, R.K., Fr. Singer, and H.E. Gruber. “Skeletal and hormonal effects of magnesium deficiency”. Journal of the
American College of Nutrition Vol. 28, No. 2 (2009): 131–141.
7. Kramer, J.H., et al. “Neurogenic inflammation and cardiac dysfunction due to hypomagnesia”. The American Journal
of the Medical Sciences Vol. 338, No. 1 (2009): 22–27.
8. Kramer, J.H., et al. “Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss
of myocardial tolerance to postischemic stress”. Experimental Biology and Medicine Vol. 228, No. 6 (2003): 665–673. 9. Chacko, S.A., et al. “Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunctionin an ethnically diverse cohort of postmenopausal women”. Diabetes Care Vol. 33, No. 2 (2010): 304–310. 10. Quaranta, S., et al. “Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet
(Sincromag) for the treatment of prementrual syndrome”. Clinical Drug Investigation Vol. 27, No. 1 (2007): 51–58. 11. Bagis, S., et al. “Is magnesium citrate treatment effective on pain, clinical parameters and functional status in
patients with fibromyalgia?” Rheumatology International Vol. 33, No. 1 (2013): 167–172.
12. El Idrissi, A., et al. “Effects of taurine on anxiety-like and locomotor behavior of mice.” Advances in Experimental
Medicine and Biology Vol. 643 (2009): 207–215.
13. Nandhini, T.A. and C.V. Anuradha. ”Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion
pump activity by taurine in RBC exposed to high glucose.” Clinica Chimica Acta Vol. 336, No. 1–2 (2003): 129–135. 14. Izzo, A.A., T.S. Gaginella, and F. Capasso. “The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric
oxide”. Magnesium Research Vol. 9, No. 2 (1996): 133–138.
15. Love, J., et al. “A multicentre, observational study of sodium picosulfate and magnesium citrate as a precolonoscopy
bowel preparation”. Canadian Journal of Gastroenterology Vol. 23, No. 10 (2009): 706–710.
16. Hoy, S.M., L.J. Scott, and A.J. Wagstaff. “Sodium picosulfate/magnesium citrate: a review of its use as a colorectal
cleanser.” Drugs Vol. 69, No. 1 (2009): 123–136.